CRIS Current Research Information System

LODATO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.219
EU - Europa 1.733
AS - Asia 706
AF - Africa 125
SA - Sud America 5
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.209
GB - Regno Unito 533
VN - Vietnam 362
SE - Svezia 292
DE - Germania 202
IT - Italia 200
CN - Cina 189
UA - Ucraina 112
IN - India 97
IE - Irlanda 84
RU - Federazione Russa 68
FR - Francia 66
CH - Svizzera 50
EE - Estonia 43
ZA - Sudafrica 41
TG - Togo 39
JO - Giordania 26
CI - Costa d'Avorio 19
NG - Nigeria 18
BG - Bulgaria 17
BE - Belgio 15
GR - Grecia 15
JP - Giappone 11
PL - Polonia 11
CA - Canada 10
IR - Iran 10
FI - Finlandia 8
SC - Seychelles 8
CZ - Repubblica Ceca 4
BR - Brasile 3
ES - Italia 3
KR - Corea 3
NL - Olanda 3
AU - Australia 2
DK - Danimarca 2
HR - Croazia 2
NO - Norvegia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EC - Ecuador 1
EU - Europa 1
HK - Hong Kong 1
IL - Israele 1
LB - Libano 1
RO - Romania 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 4.791
Salva come PNG Salva come JPEG
Città #
Southend 487
Chandler 339
Fairfield 285
Dong Ket 242
Ashburn 168
Houston 128
Wilmington 110
Woodbridge 103
Ann Arbor 99
Seattle 98
Princeton 93
Dublin 84
Cambridge 73
Jacksonville 68
Westminster 48
Bern 47
Lomé 39
Nanjing 36
Padova 33
Medford 32
Saint Petersburg 32
Boardman 28
Amman 26
Berlin 25
Dearborn 25
Abidjan 19
Abeokuta 18
Shenyang 17
Sofia 17
Bremen 16
Hebei 16
Brussels 15
Florence 15
Jinan 15
Milan 14
Nanchang 14
Turin 14
Bologna 13
Beijing 11
New York 11
Tokyo 11
Falls Church 10
Torino 10
Jiaxing 9
Mülheim 9
Norwalk 9
Mahé 8
Pune 8
San Diego 8
Changsha 7
Helsinki 7
Monmouth Junction 7
Mountain View 7
Redwood City 7
Tianjin 7
Augusta 6
Des Moines 6
Haikou 6
Hangzhou 6
Leawood 6
Guangzhou 5
Redmond 5
Rome 5
Toronto 5
Zhengzhou 5
Castelnuovo Rangone 4
Lanzhou 4
Ningbo 4
Prague 4
Verona 4
Ardabil 3
Chengdu 3
Chicago 3
Cisterna Di Latina 3
Fuzhou 3
Hanover 3
Olalla 3
Zanjan 3
Andover 2
Arlington 2
Athens 2
Changchun 2
Groningen 2
Hefei 2
Henderson 2
Izmir 2
Kuban 2
Kunming 2
London 2
Los Angeles 2
Mumbai 2
Napoli 2
North York 2
Pesaro 2
Providence 2
Sacramento 2
San Jose 2
Shanghai 2
São Paulo 2
Taiyuan 2
Totale 3.240
Salva come PNG Salva come JPEG
Nome #
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 209
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 202
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 176
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 171
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 171
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 165
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 160
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 153
Adverse effects of proton pump inhibitors. 151
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 134
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 126
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 125
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 123
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 117
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 114
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 113
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 111
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 107
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 107
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 102
Pharmacological modulation of MRP2 in primary biliary cirrhosis 98
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 97
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 93
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 92
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 92
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 91
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 90
MRP2 is upregulated by UDCA in cholestasis of pregnancy. 86
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 86
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 84
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 84
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 84
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 83
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 83
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 79
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 78
Placental MRP2 is upregulated by UDCA in cholestasis of pregnancy. 76
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 75
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 74
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 73
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 71
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression 68
Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence 63
Outcomes and survival after TIPS positioning: a single center experience 58
Outcomes and survival after TIPS positioning: a single center experience 57
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 54
Totale 4.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201988 0 0 0 0 0 0 0 0 0 0 29 59
2019/20201.187 222 29 19 64 101 143 133 157 133 68 44 74
2020/2021742 123 48 17 24 3 21 15 32 72 21 23 343
2021/20221.072 125 49 63 63 76 71 18 48 35 52 283 189
2022/20231.187 122 185 63 155 71 97 31 63 191 30 86 93
2023/2024246 13 45 13 34 19 59 9 13 28 13 0 0
Totale 4.906